Related Experiment Videos
Doxazosin, an inferior antihypertensive agent?
1Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA. cfurberg@wfubmc.edu
Journal of Human Hypertension
|May 31, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
The Journal of clinical endocrinology and metabolism·2012
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine·2006
Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.
Annals of epidemiology·2001
Prevalence of hypertension in severe vs. non-severe COVID-19: a systematic review and meta-analysis.
Journal of human hypertension·2026
Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost.
Journal of human hypertension·2026
Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement.
Journal of human hypertension·2026
Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.
Research in social & administrative pharmacy : RSAP·2026
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026